Interfering with breast cancer metastasis

Interfering with breast cancer metastasis
Breast cancer cell with protrusions for cell movement.

(Medical Xpress)—Nancy Hynes and her group at the Friedrich Miescher Institute for Biomedical Research have discovered an important mediator of breast cancer metastasis. The protein called Memo is not only required for cell migration and invasion, it is also an excellent prognostic marker for poor patient outcome and points the way to new therapeutic approaches.

Thanks to the tremendous advances in therapy in the last twenty years, patients no longer invariably die from the primary tumor in the breast but rather from metastases, cancer cells spreading to other locations. This is good news for many, but it also brought to the limelight the relative lack of understanding of the proteins and signaling cascades involved in metastasis. A better understanding of the processes controlling cancer cell motility and invasion is clearly needed to develop new anticancer approaches.

Nancy Hynes, Group leader at the Friedrich Miescher Institute for Biomedical Research, and her team have identified and further characterized a protein called Memo, which plays an essential role in the formation of . In their study published in Science Signaling they showed that Memo is required for and invasion. Their structural and biochemical analyses of Memo revealed that the protein binds copper and, as a copper-dependent redox protein, influences the oxidative milieu of a cell. This is particularly relevant because activation of a number of proteins through oxidation promotes the movement of cells.

Hynes and her collaborators further showed that Memo is an excellent prognostic marker for poor patient outcome. The abundance of Memo correlated well with many parameters of aggressive disease ‒ even better than lymph node status, the currently most important indicator of disease-free survival and overall survival in breast cancer. Hynes comments: "This finding is particularly noteworthy, because in our study we look at with a generally good prognosis. Most of them were estrogen receptor or progesterone receptor positive, showed no lymph node involvement and had low-grade tumors." Nevertheless, increased amounts of Memo were found in about 7% of the patients, which predicted early metastasis and death.

Since Memo requires copper for its activity, it is interesting to consider copper chelation therapies currently in phase 2 clinical trials. The FMI scientists showed that the copper chelator tetrathiomolybdate (TM) had a pronounced effect on the invasive ability of breast and their results suggest that Memo is one of the important targets. "We think that Memo may be one of the major copper-bound enzymes that promote invasion," said Hynes.

More information: MacDonald G, Nalvarte I, Smirnova T, Vecchi M, Aceto N, Dolemeyer A, Frei A, Lienhard S, Wyckoff J, Hess D, Seebacher J, Keusch JJ, Gut H, Salaun D, Mazzarol G, Disalvatore D, Bentires-Alj M, Di Fiore PP, Badache A, Hynes NE (2014) "Memo is a copper-dependent redox protein with an essential role in migration and metastasis." Sci Signal. 2014 Jun 10;7(329):ra56. DOI: 10.1126/scisignal.2004870.

add to favorites email to friend print save as pdf

Related Stories

Stopping the spread of breast cancer

Jun 03, 2014

The primary cause of death from breast cancer is the spread of tumor cells from the breast to other organs in the body. Northwestern Medicine® scientists have discovered a new pathway that can stop breast cancer cells from ...

New signaling pathway linked to breast cancer metastasis

Apr 02, 2012

Lymph nodes help to fight off infections by producing immune cells and filtering foreign materials from the body, such as bacteria or cancer cells. Thus, one of the first places that cancer cells are found when they leave ...

Inhibiting cell migration in breast cancer

Mar 14, 2012

(Medical Xpress) -- Scientists from the Friedrich Miescher Institute for Biomedical Research together with colleagues from the University of Fribourg have discovered a signaling mechanism controlling mobility ...

Alternative target for breast cancer drugs

Jul 19, 2013

Scientists have identified higher levels of a receptor protein found on the surface of human breast tumour cells that may serve as a new drug target for the treatment of breast cancer. The results, which are published today ...

Recommended for you

Discovery could lead to new cancer treatment

Aug 29, 2014

A team of scientists from the University of Colorado School of Medicine has reported the breakthrough discovery of a process to expand production of stem cells used to treat cancer patients. These findings could have implications ...

User comments